Straumann stock falls after Deutsche Bank cuts its rating
Published on 08/22/2026 at 12:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Straumann Holding AG (CH0012280076) stock fell after Deutsche Bank cut its rating to hold from buy and lowered its price target to CHF99 from CHF119, while the latest Q2 2026 figures showed organic revenue growth of 8.5% to CHF707 million.
As Reuters reported on August 21, 2026, the downgrade came with a 3.3% share-price drop and a warning that rising risks and a CEO transition could weigh on sentiment. The same report said the stock slipped to 92.2 Swiss francs.
What changed in the note
Deutsche Bank's view matters because it landed after a quarter that was still solid by operating standards. Straumann said its first-half 2026 core EBIT reached CHF355 million, with a margin of 25.7%, and management lifted full-year guidance for constant-currency core EBIT margin expansion to 140 to 170 basis points.
The comparison is clear: the new guidance is wider and stronger than the prior outlook of 30 to 60 basis points. That shift helps explain why the analyst call focused less on the quarter itself and more on valuation and execution risk.
Where growth came from
The Q2 2026 sales mix was broad-based. Europe grew 8.6% organically, North America 8.4%, Asia-Pacific 7.4% and Latin America 11.8%, which points to demand that was not dependent on one market.
Consensus still expects CHF2.77 billion in 2026 revenue, according to the latest analyst snapshot, implying 4.9% growth versus the prior 12 months. That gives the stock a second reference point beyond the downgrade itself.
Product line
Straumann's dental implant and orthodontic portfolio remains the core business behind the numbers, with consumables, diagnostics and implant systems still driving the operating result.
Straumann shares
As of August 21, 2026, the stock traded at 92.2 Swiss francs, down 3.3% on the day after the downgrade. MarketCap was listed at 30.811 billion CHF in the latest market snapshot.
Fact box
Company: Straumann Holding AG
ISIN: CH0012280076
Ticker: STMN
Exchange: SIX Swiss Exchange
Sector / Industry: Healthcare / Medical equipment and supplies
Price (as of August 21, 2026, 4:30 p.m. local exchange time): CHF92.2
Market cap: CHF30.811 billion
Index membership: SMI
